Categories

Tags

immunocompromised

Providing Hope: Evusheld Administration for COVID-19 Pre-Exposure Prophylaxis in Vulnerable Patient Populations
Identification
212
Date
April 13, 2023
Credits
0.75 CH | Expired April 15, 2025
In 2022, the FDA issued emergency use authorization for administration of Evusheld, comprised of two monoclonal antibody medications that help minimize the risk of severe COVID-19 disease in immunocompromised patients…
Speakers
Specialties
Clinical Topics | Research, Quality, & Safety
General
covid-19 | continuing nursing education | Evusheld | immunocompromised
Tracks
Clinical
$38
Standard Price

Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.